| Jennifer Rose Sharp, DO | |
|
3600 Nw Samaritan Dr, Corvallis, OR 97330-3737 | |
| (541) 768-4906 | |
| Not Available |
| Full Name | Jennifer Rose Sharp |
|---|---|
| Gender | Female |
| Speciality | Orthopedic Surgery |
| Experience | 9 Years |
| Location | 3600 Nw Samaritan Dr, Corvallis, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760875967 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 172122 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy San Juan Medical Center | Carmichael, CA | Hospital |
| Sutter Roseville Medical Center | Roseville, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopedic Trauma Surgeons Of Northern California | 5698781938 | 12 |
News Archive
More and more people, particularly older people, are suffering from osteoarthritis due to wear and tear on their joints. This primarily affects the knee and hip joints but also the spine. In earlier studies, scientists at MedUni Vienna Department of Orthopaedics showed that raised levels of certain proteins, so-called galectins, and their docking sites are found in patients with osteoarthritis.
A new study has shown that glial cells of the gut (part of the enteric nervous system) when exposed to secretions from colon cancer cells are convert into tumours themselves. These altered glial cells then convert into promoters of tumours said the study researchers.
When researchers from the University of Colorado Anschutz Medical Campus, Aurora, used a combination of two specific blood-clotting tests, they found critically ill patients infected with Coronavirus Disease 2019 (COVID-19) who were at high risk for developing renal failure, venous blood clots, and other complications associated with blood clots, such as stroke.
Discovering the different genes that contribute to a complex disease is like searching in the proverbial haystack for an unknown number of needles-some much smaller than others, often blending into the background, and many of them widely separated from each other.
Proteonomix, Inc., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today announced that it has entered into an exclusive worldwide license agreement for a novel source of primary human cells that secrete a factor capable of inhibiting tumor cell growth and causing tumor cell death.
› Verified 2 days ago
| Entity Name | Orthopedic Trauma Surgeons Of Northern California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821031741 PECOS PAC ID: 5698781938 Enrollment ID: O20060223000806 |
News Archive
More and more people, particularly older people, are suffering from osteoarthritis due to wear and tear on their joints. This primarily affects the knee and hip joints but also the spine. In earlier studies, scientists at MedUni Vienna Department of Orthopaedics showed that raised levels of certain proteins, so-called galectins, and their docking sites are found in patients with osteoarthritis.
A new study has shown that glial cells of the gut (part of the enteric nervous system) when exposed to secretions from colon cancer cells are convert into tumours themselves. These altered glial cells then convert into promoters of tumours said the study researchers.
When researchers from the University of Colorado Anschutz Medical Campus, Aurora, used a combination of two specific blood-clotting tests, they found critically ill patients infected with Coronavirus Disease 2019 (COVID-19) who were at high risk for developing renal failure, venous blood clots, and other complications associated with blood clots, such as stroke.
Discovering the different genes that contribute to a complex disease is like searching in the proverbial haystack for an unknown number of needles-some much smaller than others, often blending into the background, and many of them widely separated from each other.
Proteonomix, Inc., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today announced that it has entered into an exclusive worldwide license agreement for a novel source of primary human cells that secrete a factor capable of inhibiting tumor cell growth and causing tumor cell death.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Rose Sharp, DO 3600 Nw Samaritan Dr, Corvallis, OR 97330-3737 Ph: (541) 768-4906 | Jennifer Rose Sharp, DO 3600 Nw Samaritan Dr, Corvallis, OR 97330-3737 Ph: (541) 768-4906 |
News Archive
More and more people, particularly older people, are suffering from osteoarthritis due to wear and tear on their joints. This primarily affects the knee and hip joints but also the spine. In earlier studies, scientists at MedUni Vienna Department of Orthopaedics showed that raised levels of certain proteins, so-called galectins, and their docking sites are found in patients with osteoarthritis.
A new study has shown that glial cells of the gut (part of the enteric nervous system) when exposed to secretions from colon cancer cells are convert into tumours themselves. These altered glial cells then convert into promoters of tumours said the study researchers.
When researchers from the University of Colorado Anschutz Medical Campus, Aurora, used a combination of two specific blood-clotting tests, they found critically ill patients infected with Coronavirus Disease 2019 (COVID-19) who were at high risk for developing renal failure, venous blood clots, and other complications associated with blood clots, such as stroke.
Discovering the different genes that contribute to a complex disease is like searching in the proverbial haystack for an unknown number of needles-some much smaller than others, often blending into the background, and many of them widely separated from each other.
Proteonomix, Inc., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today announced that it has entered into an exclusive worldwide license agreement for a novel source of primary human cells that secrete a factor capable of inhibiting tumor cell growth and causing tumor cell death.
› Verified 2 days ago
Dr. Alexandra Makenzie, DO Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 3600 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-768-4906 | |
Cay Michael Mierisch, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3620 Nw Samaritan Dr Ste 201, Corvallis, OR 97330 Phone: 541-768-6300 | |
Dr. Andrew D Nelson, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3600 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-768-4906 | |
Dr. Leon H Malkin, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 3620 Nw Samaritan Dr, Ste 201, Corvallis, OR 97330 Phone: 541-768-6300 Fax: 541-768-6301 | |
Peter C Tsai, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2773 Nw 9th St, Corvallis, OR 97330 Phone: 541-207-0910 Fax: 541-738-2596 | |
Dr. J Noonan, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3615 Nw Samaritan Dr Ste 210, Corvallis, OR 97330 Phone: 541-768-4501 | |
Dr. Jeremy Don Brown, DO Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 3600 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-768-4906 |